To confirm that emergent dynamics follow experimental observations, we tested how outcomes vary as a function of four CAR and tumor features—CAR T-cell dose (Sampson et al., 2014), CD4+:CD8+ CAR T-cell ratio (Sommermeyer et al., 2016; Turtle et al., 2016), CAR-antigen affinity (Chmielewski et al., 2004; Hudecek et al., 2013; Caruso et al., 2015; Johnson et al., 2015; Liu et al., 2015; Ghorashian et al., 2019), and antigen density on cancer cells (Stone et al., 2012; Liu et al., 2015; Watanabe et al., 2015; Majzner et al., 2020). This evidence concerns the gene CD8A and neoplasm.